Brookfield Corp’s AstraZeneca AZN Stock Holding History

Brookfield Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-122,177	Closed	-$17.5M	–	153
2023 Q2	$17.5M	Sell	122,177 -39,561	-24%	-$5.82M	0.07%	104
2023 Q1	$22.5M	Buy	161,738 +37,680	+30%	+$5.07M	0.09%	93
2022 Q4	$16.8M	Buy	124,058 +55,934	+82%	+$7.01M	0.06%	114
2022 Q3	$7.47M	Buy	68,124 +4,583	+7%	+$581K	0.03%	211
2022 Q2	$8.4M	Buy	+63,541	New	+$8.34M	0.04%	177
2022 Q1	–	Sell	-152,507	Closed	-$17.8M	–	627
2021 Q4	$17.8M	Buy	152,507 +88,924	+140%	+$10.5M	0.07%	89
2021 Q3	$7.64M	Buy	63,583 +21,565	+51%	+$2.51M	0.03%	169
2021 Q2	$5.03M	Buy	+42,018	New	+$4.61M	0.02%	215

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return